Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas.
c-MET kinase signaling
cancer stem cells
head and neck squamous cell carcinoma
radiotherapy
resistance
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
14 Apr 2021
14 Apr 2021
Historique:
received:
26
02
2021
revised:
26
03
2021
accepted:
11
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
The receptor tyrosine kinase c-MET activates intracellular signaling and induces cell proliferation, epithelial-to-mesenchymal-transition and migration. Within the present study, we validated the prognostic value of c-MET in patients with head and neck squamous cell carcinoma (HNSCC) treated with radio(chemo)therapy using the Cancer Genome Atlas database and found an association of increased
Identifiants
pubmed: 33919702
pii: cancers13081865
doi: 10.3390/cancers13081865
pmc: PMC8070694
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Preiss-Daimler-Stipend
ID : 2019
Organisme : DKTK Dresden
ID : 2019
Références
Cancer Treat Rev. 2013 Nov;39(7):793-801
pubmed: 23453860
Clin Cancer Res. 2019 May 15;25(10):3152-3163
pubmed: 30670494
Cancer Res. 2009 Apr 1;69(7):3021-31
pubmed: 19318576
Oncogene. 2007 Feb 26;26(9):1276-85
pubmed: 17322912
J Transl Med. 2015 Aug 29;13:282
pubmed: 26319934
J Clin Oncol. 2021 Jan 1;39(1):38-47
pubmed: 33052757
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12039-44
pubmed: 14528000
Cancers (Basel). 2019 Jun 21;11(6):
pubmed: 31234336
Lancet. 2019 Jan 5;393(10166):51-60
pubmed: 30449623
Drug Saf. 2019 Feb;42(2):211-233
pubmed: 30649748
Radiother Oncol. 2017 Sep;124(3):496-503
pubmed: 28807520
J Clin Oncol. 2019 Dec 1;37(34):3266-3274
pubmed: 31618129
Oncogene. 2013 Mar 14;32(11):1428-40
pubmed: 22562252
Cell. 1994 Apr 22;77(2):261-71
pubmed: 7513258
Cell Death Dis. 2019 Jul 15;10(8):540
pubmed: 31308358
J Clin Oncol. 2006 Jun 10;24(17):2666-72
pubmed: 16763281
Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):701-7
pubmed: 24521684
Nature. 2015 Jan 29;517(7536):576-82
pubmed: 25631445
Head Neck. 2007 Apr;29(4):387-400
pubmed: 16358297
Nature. 1995 Aug 31;376(6543):768-71
pubmed: 7651534
Clin Cancer Res. 2009 Jun 1;15(11):3740-50
pubmed: 19470725
Biochem Biophys Res Commun. 2014 Nov 21;454(3):369-75
pubmed: 25451256
Radiat Oncol. 2014 Sep 19;9:207
pubmed: 25234922
Eur J Cancer. 2015 Oct;51(15):2130-2143
pubmed: 26421817
Clin Cancer Res. 2012 Apr 15;18(8):2269-77
pubmed: 22374333
Surg Oncol Clin N Am. 2015 Jul;24(3):379-96
pubmed: 25979389
Anticancer Res. 2015 Nov;35(11):5973-82
pubmed: 26504020
Clin Cancer Res. 2009 Apr 1;15(7):2207-14
pubmed: 19318488
Radiother Oncol. 2014 Feb;110(2):362-9
pubmed: 24440046
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
CA Cancer J Clin. 2013 Jul-Aug;63(4):249-79
pubmed: 23716430
Cancer Res. 2012 Sep 1;72(17):4537-50
pubmed: 22738909
Radiother Oncol. 2007 Jun;83(3):304-10
pubmed: 17517444
J Clin Oncol. 2012 Sep 10;30(26):3287-96
pubmed: 22869872
Lancet Oncol. 2008 Mar;9(3):288-96
pubmed: 18308254
Nat Med. 2012 Jan 22;18(2):221-3
pubmed: 22270724
Int J Cancer. 2019 Dec 15;145(12):3299-3310
pubmed: 31135957
Med Oncol. 2018 Nov 26;36(1):8
pubmed: 30478503
Invest New Drugs. 2013 Apr;31(2):417-24
pubmed: 22918720
Biochem Biophys Res Commun. 2014 Jun 20;449(1):49-54
pubmed: 24802404
Oncotarget. 2016 Jul 19;7(29):45122-45133
pubmed: 27281611
J Clin Oncol. 2008 Jun 10;26(17):2871-5
pubmed: 18539966
Oncogene. 2008 Jan 24;27(5):684-93
pubmed: 17684486
Clin Transl Radiat Oncol. 2019 Mar 18;16:40-47
pubmed: 30993218
Nat Rev Mol Cell Biol. 2010 Dec;11(12):834-48
pubmed: 21102609
Nature. 1989 Nov 23;342(6248):440-3
pubmed: 2531289
Cancers (Basel). 2021 Jan 18;13(2):
pubmed: 33477635
Radiother Oncol. 2016 Dec;121(3):364-373
pubmed: 27913065
Front Cell Dev Biol. 2020 May 06;8:152
pubmed: 32435640
J Thorac Oncol. 2018 May;13(5):682-688
pubmed: 29518553
Int J Cancer. 2012 Feb 1;130(3):728-34
pubmed: 21400509
J Cell Biol. 2000 Sep 18;150(6):1375-84
pubmed: 10995442
Clin Cancer Res. 2008 Oct 1;14(19):5941-6
pubmed: 18829470
Ann Oncol. 2015 Jun;26(6):1216-1223
pubmed: 25712460
Cell Death Dis. 2018 Feb 14;9(2):237
pubmed: 29445192
Cancers (Basel). 2017 Apr 24;9(4):
pubmed: 28441771
Oral Oncol. 2012 Jan;48(1):1-9
pubmed: 22070916
J Cell Biochem Suppl. 1993;17F:188-91
pubmed: 8412192
Clin Cancer Res. 2004 Dec 15;10(24):8204-13
pubmed: 15623595
Clin Cancer Res. 2016 Jun 1;22(11):2639-49
pubmed: 26755529
Oncologist. 2019 Oct;24(10):1305-1308
pubmed: 31391294
Clin Cancer Res. 2020 Jul 15;26(14):3616-3628
pubmed: 32161122
Mol Oncol. 2020 Jun;14(6):1185-1206
pubmed: 32336009
Cancers (Basel). 2013 Nov 26;5(4):1601-18
pubmed: 24287743
Anticancer Res. 1998 Nov-Dec;18(6B):4793-800
pubmed: 9891559
Clin Transl Radiat Oncol. 2016 Dec 22;1:19-26
pubmed: 29657990
Stem Cells Int. 2016;2016:1894782
pubmed: 26880935
Eur J Cancer. 2008 Mar;44(5):641-51
pubmed: 18295476
Nat Rev Drug Discov. 2008 Jun;7(6):504-16
pubmed: 18511928
Oncotarget. 2015 Oct 27;6(33):34494-509
pubmed: 26460734
Biomedicines. 2014 Dec 31;3(1):1-31
pubmed: 28536396
Am Soc Clin Oncol Educ Book. 2016;35:e284-92
pubmed: 27249734
Oral Oncol. 2007 Nov;43(10):1021-5
pubmed: 17306605
JAMA Otolaryngol Head Neck Surg. 2016 Sep 1;142(9):842-9
pubmed: 27389475